Silverlake Wealth Management’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $581K | Sell |
5,410
-8
| -0.1% | -$859 | 0.17% | 143 |
|
2025
Q1 | $547K | Sell |
5,418
-234
| -4% | -$23.6K | 0.21% | 121 |
|
2024
Q4 | $505K | Sell |
5,652
-38
| -0.7% | -$3.39K | 0.19% | 128 |
|
2024
Q3 | $477K | Hold |
5,690
| – | – | 0.18% | 138 |
|
2024
Q2 | $438K | Sell |
5,690
-402
| -7% | -$31K | 0.18% | 138 |
|
2024
Q1 | $417K | Sell |
6,092
-6
| -0.1% | -$411 | 0.21% | 128 |
|
2023
Q4 | $353K | Sell |
6,098
-33
| -0.5% | -$1.91K | 0.19% | 138 |
|
2023
Q3 | $324K | Sell |
6,131
-649
| -10% | -$34.3K | 0.18% | 150 |
|
2023
Q2 | $367K | Sell |
6,780
-18
| -0.3% | -$974 | 0.2% | 131 |
|
2023
Q1 | $340K | Buy |
6,798
+32
| +0.5% | +$1.6K | 0.21% | 132 |
|
2022
Q4 | $313K | Hold |
6,766
| – | – | 0.2% | 133 |
|
2022
Q3 | $262K | Sell |
6,766
-215
| -3% | -$8.33K | 0.18% | 143 |
|
2022
Q2 | $260K | Hold |
6,981
| – | – | 0.17% | 154 |
|
2022
Q1 | $309K | Sell |
6,981
-415
| -6% | -$18.4K | 0.18% | 151 |
|
2021
Q4 | $314K | Buy |
+7,396
| New | +$314K | 0.17% | 146 |
|